Personalized Medicine’s Impact on Cancer CareVideo Categories: Personalized Medicine
Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.
Dr. S. Yosuf Zafar has found that out of pocket costs impact patient well-being, quality of life, and quality of care. He stresses that costs need to be reduced in order to provide the best medical treatment for all patients.